A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke

Annals of Indian Academy of Neurology

Volumn 14, Issue 2, 2011, Pages 103-106

  Sharma, Pawan ^a   Sinha, Manish ^a   Shukla, R K ^a   Garg, R ^a   Verma, R ^a   Singh, M K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Edaravone; free radical scavenger; neuroprotection; stroke

Indexed keywords

NORPHENAZONE; SODIUM CHLORIDE;

ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LIVER FUNCTION; MALE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 79960202053     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.82794     Document Type: Article

References (13)

1. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006;12:9-20. (Pubitemid 44133577)
2. Suda S, Igarashi H, Arai Y, Andou J, Chishiki T, Katayama Y. Effect of edaravone, a free radical scavenger on ischemic cerebral edema assessed by magnetic resonance imaging. Neurol Med Chir (Tokyo) 2007;47:197-201 (Pubitemid 46827882)
3. Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222-9.
4. Mishina M, Komaba Y, Kobayashi S, Tanaka N, Kominami S, Fukuchi T, et al. Efficacy of edaravone, a free radical scavenger for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 2005;45:344-8. (Pubitemid 41301697)
5. Inatomi Y, Takita T, Yonehara T, Fujioka S, Hashimoto Y, Hirano T, et al. Efficacy of edaravone in cardioembolic stroke. Intern Med 2006;45:253-7.
6. Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, et al. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 2004;221:11-7. (Pubitemid 38721285)
7. Sulter G, Steen C, De Keyser J. Use of the Barthel index and Modified Rankin Scale in acute stroke trials. Stroke 1999;30:1538-41. (Pubitemid 29379599)
8. Hatano S. Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ 1976;54:541-53. (Pubitemid 8114220)
9. Goldstein LB, Jones MR, Matchar DB, Edwards LJ, Hoff J, Chilukuri V, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001;32:1091-8.
10. Otomo E, Tohgi H, Kogure K, Hirai S, Terashi A, Gotoh F, et al. Clinical efficacy of a free radical scavenger, MCI-186, on acute cerebral infarction: Early phase II clinical trial. Ther Res 1998;19:531-52. (Pubitemid 28457542)
11. Sinha MK, Anuradha HK, Juyal R, Shukla R, Garg RK, Kar AM. Edaravone in acute ischemic stroke, An Indian experience. Neurology Asia 2009;14:7-10.
12. Abe M, Kaizu K, Matsumoto K. A case report of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient. Ther Apher Dial 2007;11:235-40. (Pubitemid 46716169)
13. Hishida A. Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance. Clin Exp Nephrol 2007;11:292-6. (Pubitemid 350277612)